Alexander Dreval - Dept Clin Endocrinol, Postgrad Educ Fac, MF Vladimirsky Moscow Reg Res Clin Inst

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 69 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

#1705024 A Randomized Phase 3 Trial to Assess Efficacy and Safety of a Novel Formulation of Octreotide Subcutaneous Depot (CAM2029) in Patients with Acromegaly

Julie Silverstein,Diego Ferone,Pamela Freda,Laurence Katznelson,Federico Gatto,Pinar Kadioglu,Pietro Maffei,Jochen Seufert,Joanna L. Spencer-Segal,Elena Isaeva,Alexander Dreval,Maria Harrie,Agneta Svedberg,Fredrik Tiberg

Endocrine Practiceno. 5 (2024): S117-S118

引用0浏览0引用

A Randomised Phase 3 Trial to Assess Efficacy and Safety of CAM2029, an Octreotide Subcutaneous Depot, in Patients with Acromegaly

Diego Ferone,Julie Silverstein,Pamela Freda,Laurence Katznelson,Federico Gatto,Pinar Kadioglu, Pietro Maffei,Jochen Seufert,Spencer-Segal Joanna L.,Elena Isaeva,Alexander Dreval,Maria Harrie,Agneta Svedberg,Fredrik Tiberg

Endocrine Abstracts (2024)

引用0浏览0引用

Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial, ACROINNOVA 1

Diego Ferone,Pamela Freda,Laurence Katznelson, Federico Gatto,Pinar Kadioğlu, Pietro Maffei,Jochen Seufert, Julie M Silverstein, Joanna L Spencer-Segal,Elena Isaeva,Alexander Dreval, Maria Harrie, Agneta Svedberg,Fredrik Tiberg

The Journal of clinical endocrinology and metabolism (2024)

引用0浏览0WOS引用

An Open-Label Long-Term Phase 3 Study of CAM2029 in Patients with Acromegaly (ACROINNOVA 2): Interim Analysis of the Subgroup of Patients 'new to CAM2029' with Controlled or Uncontrolled Acromegaly on Standard-of-care Treatment

Diego Ferone,Spencer-Segal Joanna L.,Yaylali Guzin Fidan, Mirjana Doknic,Elena Isaeva,Alexander Dreval, Aleksandra Gilis-Januszewska, Emre Gezer, Irina Bancos,Laurence Katznelson,Maria Harrie,Agneta Svedberg,Pedroncelli Alberto M.,Fredrik Tiberg

Endocrine Abstracts (2024)

引用0浏览0引用

An Open-Label Long-Term Phase 3 Study of CAM2029, an Octreotide Subcutaneous Depot, in Patients with Acromegaly (ACROINNOVA 2): Interim Analysis of the ACROINNOVA 1 Roll-over Patients Subgroup

Endocrine Abstracts (2024)

引用0浏览0引用

THU057 Predictors of Response to Oral Octreotide Capsules in Patients with Acromegaly in A Large Prospective International Trial

Maria Fleseriu,Alexander Dreval,Yulia Pokramovich,Irina Bondar,Elena Isaeva,Djuro Macut,Mark E. Molitch,Nina Leonova,Gérald Raverot,Asi Haviv,Nienke R. Biermasz,Christian J. Strasburger,Shlomo Melmed

Journal of the Endocrine Societyno. Supplement_1 (2023)

引用0浏览0引用

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial (vol 10, pg 102, 2022)

M. Fleseriu,A. Dreval,I Bondar

LANCET DIABETES & ENDOCRINOLOGYno. 3 (2022): E3-E3

引用14浏览0引用

Gliclazide MR in the Structure of Antihyperglycemic Therapy According to the Data of Moscow Region Diabetes Register

Inna Misnikova,Yulia A. Kovaleva,Valeria A. Gubkina,Alexander Dreval

Diabetes Mellitus（2022）

引用0浏览0引用

Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly: Mpowered Trial Open-Label Extension Phase

Maria Fleseriu,Mark E. Molitch,Alexander Dreval,Yulia Pokramovich,Ирина Аркадьевна Бондарь,Yury Poteshkin,Djuro Macut,Barbara Obermayer‐Pietsch,Yossi Gilgun‐Sherki,Asi Haviv,Nienke R. Biermasz,Шломо Мелмед,Christian J. Strasburger

Endocrine Abstracts (2022)

引用3浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn